Zobrazeno 1 - 10
of 108
pro vyhledávání: '"L. Fearfield"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical and Experimental Dermatology. 46:1142-1145
Autor:
C. L. Edwards, S. Agraso Busto, James Larkin, Kara Heelan, L. Fearfield, Samra Turajlic, F. Comito, C. Harland
Publikováno v:
Clinical and Experimental Dermatology. 46:338-341
Checkpoint inhibitor (CPI) therapy has significantly improved overall survival for metastatic melanoma, and is now approved for use in the adjuvant setting. Modulating the immune system is recognized to cause cutaneous immune-related adverse events (
Publikováno v:
Clinical and Experimental Dermatology
Autor:
N. P. Patel, L. Fearfield
Publikováno v:
Clinical and experimental dermatology. 46(6)
As many countries start to recover from a second wave of COVID-19 infection, the dermatology community must now seriously consider how it wishes dermatology services to be provided in future. The speed at which the pandemic accelerated in spring 2020
Autor:
L. Ferguson, L. Fearfield
Publikováno v:
Clinical and experimental dermatology. 44(4)
Publikováno v:
Clinical and Experimental Dermatology. 41:267-271
We report three cases of skin toxicity associated with oral mitogen-activated protein kinase kinase (MEK) inhibitor treatment for metastatic malignant melanoma (MM). All three patients developed oedema, and a single patient experienced eyelash tricho
Publikováno v:
Clinical and Experimental Dermatology. 39:612-615
Morphoea is a localized inflammatory disorder of the dermis and subcutaneous fat and radiotherapy is a rarely reported cause (estimated incidence of 2 per 1000). Morphoea is commonly mistaken for an inflammatory recurrence of breast cancer, resulting
Autor:
L. Ferguson, L. Fearfield
Publikováno v:
Clinical and Experimental Dermatology. 43:817-818
Autor:
C. Edwards, L. Fearfield
Publikováno v:
Clinical and Experimental Dermatology. 43:609-610